Revisiting CB1 cannabinoid receptor detection and the exploration of its interacting partners
暂无分享,去创建一个
A. Zimmer | P. Esteban | A. Arévalo-Martı́n | E. Molina-Holgado | D. Garcia-Ovejero | R. Moreno-Luna | B. Paniagua-Torija | Luis F. Arredondo
[1] K. Daniels,et al. Assessment of quality and consistency of monoclonal antibodies for CB1 and CB2 in head and neck squamous cell carcinoma , 2019, Head & neck.
[2] A. Köfalvi,et al. Chronic insulinopenia/hyperglycemia decreases cannabinoid CB1 receptor density and impairs glucose uptake in the mouse forebrain , 2019, Brain Research Bulletin.
[3] H. Duan,et al. Expression of Cannabinoid Receptors in Myometrium and its Correlation With Dysmenorrhea in Adenomyosis , 2019, Reproductive Sciences.
[4] R. Ramer,et al. Anti‐tumour actions of cannabinoids , 2018, British journal of pharmacology.
[5] J. Fernández-Ruiz. The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid‐based therapies to improve on the poor current therapeutic outcomes , 2018, British journal of pharmacology.
[6] M. García-Arencibia,et al. Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells , 2018, British journal of pharmacology.
[7] A. Lichtman,et al. Methylphenidate modifies the motion of the circadian clock Lamotrigine in mood disorders and cocaine dependence Cortical glutamate in postpartum depression The Endogenous Cannabinoid System : A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain , 2017 .
[8] Victoria Chapman,et al. The cannabinoid system and pain , 2017, Neuropharmacology.
[9] J. Egan,et al. Targeted proteomics of cannabinoid receptor CB1 and the CB1b isoform , 2017, Journal of pharmaceutical and biomedical analysis.
[10] K. Mackie,et al. Discovery and characterization of two novel CB1 receptor splice variants with modified N‐termini in mouse , 2017, Journal of neurochemistry.
[11] S. Tenzer,et al. Cell Type-Specific Tandem Affinity Purification of the Mouse Hippocampal CB1 Receptor-Associated Proteome. , 2016, Journal of proteome research.
[12] G. Gruden,et al. Role of the endocannabinoid system in diabetes and diabetic complications , 2016, British journal of pharmacology.
[13] G. Velasco,et al. Anticancer mechanisms of cannabinoids. , 2016, Current oncology.
[14] B. Lutz,et al. The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons , 2015, PLoS biology.
[15] P. Robledo,et al. Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors , 2015, PLoS biology.
[16] P. Piazza,et al. Cannabinoid control of brain bioenergetics: Exploring the subcellular localization of the CB1 receptor , 2014, Molecular metabolism.
[17] J. Kukkonen,et al. Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors. , 2014, Biochemical and biophysical research communications.
[18] F. Lee,et al. Delineation of Domains Within the Cannabinoid CB1 and Dopamine D2 Receptors That Mediate the Formation of the Heterodimer Complex , 2014, Journal of Molecular Neuroscience.
[19] R. Laprairie,et al. Co-expression of the human cannabinoid receptor coding region splice variants (hCB₁) affects the function of hCB₁ receptor complexes. , 2013, European journal of pharmacology.
[20] P. Rakic,et al. Antibodies to cannabinoid type 1 receptor co‐react with stomatin‐like protein 2 in mouse brain mitochondria , 2013, The European journal of neuroscience.
[21] S. Angers,et al. Novel, gel-free proteomics approach identifies RNF5 and JAMP as modulators of GPCR stability. , 2013, Molecular endocrinology.
[22] D. Braun,et al. Structure and function analyses of the purified GPCR human vomeronasal type 1 receptor 1 , 2011, Scientific reports.
[23] D. Braun,et al. A Robust and Rapid Method of Producing Soluble, Stable, and Functional G-Protein Coupled Receptors , 2011, PloS one.
[24] R. Challiss. Receptor Signal Transduction Protocols , 1997, Methods in Molecular Biology.
[25] M. von Zastrow,et al. Analysis of GPCR localization and trafficking. , 2011, Methods in molecular biology.
[26] N. Birdsall. Class A GPCR heterodimers: evidence from binding studies. , 2010, Trends in pharmacological sciences.
[27] F. Bermúdez-Silva,et al. The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning? , 2010, Pharmacology Biochemistry and Behavior.
[28] Masahiko Watanabe,et al. Endocannabinoid-mediated control of synaptic transmission. , 2009, Physiological reviews.
[29] E. S. Graham,et al. Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal! , 2008, Journal of Neuroscience Methods.
[30] J. Sallés,et al. Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates , 2006, Neuroscience.
[31] Lakshmi A Devi,et al. μ opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis , 2006, British journal of pharmacology.
[32] E. Persson,et al. Expression of functional CB1 cannabinoid receptors in retinoic acid‐differentiated P19 embryonal carcinoma cells , 2006, Journal of neuroscience research.
[33] V. Marzo,et al. Endocannabinoid control of food intake and energy balance , 2005, Nature Neuroscience.
[34] D. Piomelli. The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.
[35] G. von Heijne,et al. Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail. , 2003, Molecular pharmacology.
[36] D. Bilkey,et al. Cannabinoid CB1 receptor protein expression in the rat hippocampus and entorhinal, perirhinal, postrhinal and temporal cortices: regional variations and age-related changes , 2003, Brain Research.
[37] I. Díaz-Laviada,et al. Expression of functionally active cannabinoid receptor CB1 in the human prostate gland , 2003, The Prostate.
[38] K. Mackie,et al. Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. , 2002, Chemistry and physics of lipids.
[39] G. Gessa,et al. Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid. , 2002, European journal of endocrinology.
[40] C. Deber,et al. Interhelical hydrogen bonds in the CFTR membrane domain , 2001, Nature Structural Biology.
[41] A. Howlett,et al. The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. , 2000, Molecular pharmacology.
[42] M. Parker,et al. Expression of cannabinoid receptors and their gene transcripts in human blood cells , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[43] M. Herkenham,et al. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] J. Henry,et al. SDS-resistant aggregation of membrane proteins: application to the purification of the vesicular monoamine transporter. , 1996, The Biochemical journal.
[45] A. Howlett,et al. Rat brain cannabinoid receptors are N-linked glycosylated proteins. , 1995, Life sciences.
[46] M. Kaghad,et al. An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing (*) , 1995, The Journal of Biological Chemistry.
[47] G. Cabral,et al. Expression of a cannabinoid receptor in baculovirus-infected insect cells. , 1994, Biochemical pharmacology.
[48] K. Mackie,et al. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Herkenham,et al. Cannabinoid receptor localization in brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.